Simulations Plus Inc
SLP17.130USD
-0.580-3.27%
Close 11/07, 16:00（ET）Quotes delayed by 15 min
344.59MMarket Cap
LossP/E TTM
More Details of Simulations Plus Inc Company
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Simulations Plus Inc Info
Ticker SymbolSLP
Company nameSimulations Plus Inc
IPO dateJun 18, 1997
CEOMr. Shawn M. O'Connor
Number of employees243
Security typeOrdinary Share
Fiscal year-endJun 18
Address800 Park Offices Drive, Suite 401
CityRESEARCH TRIANGLE PARK
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code27709
Phone16617237723
Websitehttps://www.simulations-plus.com/
Ticker SymbolSLP
IPO dateJun 18, 1997
CEOMr. Shawn M. O'Connor
Company Executives of Simulations Plus Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.29M
+0.05%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
68.87K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
13.28K
+15.39%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
10.70K
+19.84%
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Shawn M. O'Connor
Mr. Shawn M. O'Connor
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven Chang
Mr. Steven Chang
Global Head - Strategic Alliances
Global Head - Strategic Alliances
--
--
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.29M
+0.05%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
68.87K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
13.28K
+15.39%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
10.70K
+19.84%
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Software licenses
12.62M
61.95%
Consulting services
7.75M
38.05%
By RegionUSD
Name
Revenue
Proportion
Americas
14.54M
71.42%
Europe
3.70M
18.16%
Asia
2.12M
10.42%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Software licenses
12.62M
61.95%
Consulting services
7.75M
38.05%
Shareholding Stats
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Woltosz (Walter S)
16.34%
BlackRock Institutional Trust Company, N.A.
11.18%
The Vanguard Group, Inc.
4.84%
Janus Henderson Investors
4.04%
State Street Investment Management (US)
3.35%
Other
60.26%
Shareholders
Shareholders
Proportion
Woltosz (Walter S)
16.34%
BlackRock Institutional Trust Company, N.A.
11.18%
The Vanguard Group, Inc.
4.84%
Janus Henderson Investors
4.04%
State Street Investment Management (US)
3.35%
Other
60.26%
Shareholder Types
Shareholders
Proportion
Investment Advisor
40.85%
Investment Advisor/Hedge Fund
26.00%
Individual Investor
17.28%
Hedge Fund
6.31%
Research Firm
3.90%
Pension Fund
1.66%
Bank and Trust
1.07%
Venture Capital
0.10%
Insurance Company
0.03%
Other
2.80%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
399
16.03M
79.65%
-2.66M
2025Q2
397
20.10M
99.87%
-2.39M
2025Q1
405
20.80M
103.44%
-1.07M
2024Q4
395
19.75M
98.32%
-353.54K
2024Q3
400
19.32M
96.55%
-155.06K
2024Q2
401
20.11M
100.50%
-787.76K
2024Q1
398
20.05M
100.34%
-310.16K
2023Q4
390
19.56M
97.97%
-570.84K
2023Q3
390
19.23M
96.46%
-1.16M
2023Q2
406
19.53M
98.02%
-1.10M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Woltosz (Walter S)
3.31M
16.43%
+2.07K
+0.06%
Aug 01, 2025
BlackRock Institutional Trust Company, N.A.
2.25M
11.18%
-38.54K
-1.68%
Jun 30, 2025
The Vanguard Group, Inc.
1.17M
5.82%
+76.28K
+6.96%
Jun 30, 2025
Janus Henderson Investors
813.16K
4.04%
-83.18K
-9.28%
Jun 30, 2025
State Street Investment Management (US)
673.69K
3.35%
-32.82K
-4.65%
Jun 30, 2025
Columbia Threadneedle Investments (UK)
601.59K
2.99%
+178.79K
+42.29%
Jun 30, 2025
Tributary Capital Management, LLC
361.28K
1.79%
-28.63K
-7.34%
Jun 30, 2025
Millennium Management LLC
554.88K
2.76%
+504.90K
+1010.23%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
485.40K
2.41%
+9.87K
+2.08%
Jun 30, 2025
Geode Capital Management, L.L.C.
397.85K
1.98%
+12.00K
+3.11%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
SPDR FactSet Innovative Technology ETF
0.5%
Global X HealthTech ETF
0.31%
First Trust Active Factor Small Cap ETF
0.24%
First Trust Multi-Manager Small Cap Opportunities ETF
0.18%
Franklin Exponential Data ETF
0.11%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.08%
Principal U.S. Small-Cap ETF
0.05%
iShares Micro-Cap ETF
0.05%
iShares Russell 2000 Growth ETF
0.02%
Proshares Ultra Russell 2000
0.01%
View more
SPDR FactSet Innovative Technology ETF
Proportion0.5%
Global X HealthTech ETF
Proportion0.31%
First Trust Active Factor Small Cap ETF
Proportion0.24%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion0.18%
Franklin Exponential Data ETF
Proportion0.11%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proportion0.08%
Principal U.S. Small-Cap ETF
Proportion0.05%
iShares Micro-Cap ETF
Proportion0.05%
iShares Russell 2000 Growth ETF
Proportion0.02%
Proshares Ultra Russell 2000
Proportion0.01%
Dividend
A total of
23.51M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jul 02, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 05, 2024 going ex on Jul 29, 2024
Jul 29, 2024
Aug 05, 2024
Jul 29, 2024
Apr 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 06, 2024 going ex on Apr 26, 2024
Apr 29, 2024
May 06, 2024
Apr 26, 2024
Jan 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 05, 2024 going ex on Jan 26, 2024
Jan 29, 2024
Feb 05, 2024
Jan 26, 2024
Oct 25, 2023
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 06, 2023 going ex on Oct 27, 2023
Oct 30, 2023
Nov 06, 2023
Oct 27, 2023
Jul 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 07, 2023 going ex on Jul 28, 2023
Jul 31, 2023
Aug 07, 2023
Jul 28, 2023
Apr 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 01, 2023 going ex on Apr 21, 2023
Apr 24, 2023
May 01, 2023
Apr 21, 2023
Jan 05, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 06, 2023 going ex on Jan 27, 2023
Jan 30, 2023
Feb 06, 2023
Jan 27, 2023
Oct 20, 2022
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 07, 2022 going ex on Oct 28, 2022
Oct 31, 2022
Nov 07, 2022
Oct 28, 2022
Jul 07, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 01, 2022 going ex on Jul 22, 2022
Jul 25, 2022
Aug 01, 2022
Jul 22, 2022
Apr 06, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 02, 2022 going ex on Apr 22, 2022
Apr 25, 2022
May 02, 2022
Apr 22, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
